| abstract |
The present invention provides a novel lipopeptide comprising a peptide (Fc-binding peptide, FcBP) that specifically binds to the Fc region of an antibody, a lipid nanoparticle comprising the same, an antigen recognition type in which the antibody is non-covalently bound to the lipid nanoparticle. A pharmaceutical composition comprising lipid nanoparticles, the antigen- recognition lipid nanoparticles and a drug, and a use of the lipopeptides, the lipid nanoparticles or the antigen- recognition lipid nanoparticles for the preparation of antigen-specific drug carriers. |